Intelligene

Intelligene Financing Cash Flow

The Net Financing Cash Flow of Intelligene (7832.TWO) as of Oct 21, 2026 is 2.47 M TWD. In the previous year, Net Financing Cash Flow was 766.40 M TWD — a change of -99.68% (lower).

Financing Cash Flow

2.47 MTWD

YoY

-99.68%

Last updated:

Net Financing Cash Flow of Intelligene is 2024 2.47 M TWD. Net Financing Cash Flow of Intelligene was 2023 766.40 M TWD. It decreases by -99.68% lower compared to the previous year.

The Intelligene Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2023
766.40 M TWD
Jan 1, 2024
2.47 M TWD
The Intelligene Financing Cash Flow history
YEARFinancing Cash FlowYoY
2.47 MTWD-99.68%
766.40 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intelligene Stock analysis

What does Intelligene do? Intelligene Inc develops innovative RNA gene therapy drugs using siRNA gene compilation technology for treating pneumonia and influenza. The company focuses on research and development of nucleic acid drugs targeting all cases of pneumonia and influenza. Intelligene Inc is a Taiwan-based company with 20 full-time employees operating in the pharmaceutical industry. The company's primary revenue comes from the development and potential commercialization of its RNA-based gene therapy drugs. Intelligene Inc is engaged in the research and development of innovative nucleic acid drugs based on siRNA technology for pneumonia and influenza treatments. The firm aims to provide novel therapeutic solutions for respiratory diseases through its proprietary technology. Intelligene Inc's products target medical professionals and healthcare institutions seeking advanced treatments for pneumonia and influenza. The company's research focuses on developing drugs that address all cases of these respiratory conditions. The firm operates within the pharmaceutical sector with a specific emphasis on RNA-based therapies for respiratory illnesses. Intelligene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intelligene stock

Net Financing Cash Flow of Intelligene is 2.47 M TWD in 2024.

Net Financing Cash Flow of Intelligene changed from 766.40 M TWD to 2.47 M TWD, representing a -99.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Intelligene since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Intelligene historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Intelligene

All Key Metrics — Intelligene